FDA Accepts BioMarin's Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Adults with Severe Hemophilia APRNewsWire • 10/12/22
Wall Street Analysts See a 31% Upside in BioMarin (BMRN): Can the Stock Really Move This High?Zacks Investment Research • 10/12/22
BioMarin (BMRN) Starts Restructuring Moves to Increase EfficiencyZacks Investment Research • 10/07/22
BioMarin to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, October 26, at 4:30pm ETPRNewsWire • 10/04/22
BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDAPRNewsWire • 09/29/22
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarinInvestors Business Daily • 09/15/22
BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assessed to Provide Substantial Cost Savings Per Patient in a Preliminary Independent ReportPRNewsWire • 09/15/22
First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec), Approved by European Commission (EC)PRNewsWire • 08/24/22
BIOMARIN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRNPRNewsWire • 08/13/22
BioMarin Pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/04/22
BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line GuidancePRNewsWire • 08/03/22
These eight health-care stocks can keep you invested in the market with less worryMarket Watch • 08/02/22
BioMarin to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, August 3, at 4:30pm ETPRNewsWire • 07/20/22
BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress July 9-12, Including 4 Oral and 2 Poster PresentationsPRNewsWire • 07/11/22
5 Sizzling Goldman Sachs Conviction List Stocks to Buy Now With 100% or More Upside Potential24/7 Wall Street • 06/29/22